Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Forbes

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
The Lancet. Oncology|March 29, 2011
Preventive therapy for breast cancer: a consensus statementJack Cuzick, Andrea DeCensi, Banu Arun, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
BMJ Open|February 26, 2013
Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetesAnne Douglas, Raj S Bhopal, Ruby Bhopal, et al.
Annals of Surgical Oncology|March 25, 2011
Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus ConferenceMasakazu Toi, Eric P Winer, Takashi Inamoto, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
Critical Care Medicine|August 14, 2013
Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trialTimothy S Walsh, Julia A Boyd, Douglas Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancerJack Cuzick, Mitch Dowsett, Silvia Pineda, et al.
Diabetes Care|April 6, 2011
Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trialJason M R Gill, Raj Bhopal, Anne Douglas, et al.
The New England Journal of Medicine|August 21, 2009
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer, Henning Mouridsen, Anita Giobbie-Hurder, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
The Lancet. Oncology|March 29, 2011
Preventive therapy for breast cancer: a consensus statementJack Cuzick, Andrea DeCensi, Banu Arun, et al.
Breast Cancer Research and Treatment|February 9, 2008
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93Beat Thürlimann, Karen N Price, Richard D Gelber, et al.
BMJ Open|February 26, 2013
Design and baseline characteristics of the PODOSA (Prevention of Diabetes & Obesity in South Asians) trial: a cluster, randomised lifestyle intervention in Indian and Pakistani adults with impaired glycaemia at high risk of developing type 2 diabetesAnne Douglas, Raj S Bhopal, Ruby Bhopal, et al.
Annals of Surgical Oncology|March 25, 2011
Identifying gaps in the locoregional management of early breast cancer: highlights from the Kyoto Consensus ConferenceMasakazu Toi, Eric P Winer, Takashi Inamoto, et al.
Lancet (London, England)|December 17, 2013
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trialJack Cuzick, Ivana Sestak, John F Forbes, et al.
Endocrine-Related Cancer|July 20, 2007
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction modelRichard J Santen, Norman F Boyd, Rowan T Chlebowski, et al.
Critical Care Medicine|August 14, 2013
Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trialTimothy S Walsh, Julia A Boyd, Douglas Watson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancerJack Cuzick, Mitch Dowsett, Silvia Pineda, et al.
Diabetes Care|April 6, 2011
Sitting time and waist circumference are associated with glycemia in U.K. South Asians: data from 1,228 adults screened for the PODOSA trialJason M R Gill, Raj Bhopal, Anne Douglas, et al.
The New England Journal of Medicine|August 21, 2009
Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer, Henning Mouridsen, Anita Giobbie-Hurder, et al.
Pageof 9